← Back to Search

ABBT for Mental Health in LGBTQ+ Community

Phase 2
Recruiting
Led By Ethan Moitra, Ph.D.
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 39 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will establish the effectiveness of ABBT, a brief acceptance-based behavioral therapy, in increasing social support for LGBTQ+ people and improving their mental health.

Who is the study for?
This trial is for English-speaking adults over 18 who identify as LGBTQ+ and are experiencing mild or greater anxiety and/or depression. Participants must be seeking any clinical care at the recruitment clinic.
What is being tested?
The study compares usual treatment methods with a brief Acceptance-Based Behavior Therapy (ABBT) to see if ABBT can better improve mental health by increasing social support among LGBTQ+ individuals.
What are the potential side effects?
Since this trial involves therapy, there may not be physical side effects like with medication. However, participants might experience emotional discomfort discussing personal issues during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~39 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 39 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hamilton Anxiety Rating Scale (HAM-A)
Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)
Secondary study objectives
Generalized Anxiety Disorder-7 (GAD-7)
Patient Health Questionnaire-9 (PHQ-9)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment-as-Usual (TAU)Experimental Treatment1 Intervention
Control participants will receive the currently recommended best practices of care at the recruitment site.
Group II: Acceptance-Based Behavior Therapy (ABBT)Experimental Treatment1 Intervention
The 2-session ABBT will be delivered remotely or in-person, depending on preference.

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
466 Previous Clinical Trials
698,830 Total Patients Enrolled
30 Trials studying Depression
11,502 Patients Enrolled for Depression
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,893 Total Patients Enrolled
701 Trials studying Depression
260,868 Patients Enrolled for Depression
Ethan Moitra, Ph.D.Principal InvestigatorBrown University
2 Previous Clinical Trials
48 Total Patients Enrolled

Media Library

Acceptance-Based Behavior Therapy (ABBT) Clinical Trial Eligibility Overview. Trial Name: NCT05540067 — Phase 2
Depression Research Study Groups: Acceptance-Based Behavior Therapy (ABBT), Treatment-as-Usual (TAU)
Depression Clinical Trial 2023: Acceptance-Based Behavior Therapy (ABBT) Highlights & Side Effects. Trial Name: NCT05540067 — Phase 2
Acceptance-Based Behavior Therapy (ABBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05540067 — Phase 2
~70 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top